Articles in Point of View

The Execution Decade: Why Clinical Trials Are Pharma’s 2026 R&D Bottleneck

IQVIA’s Global Trends in R&D 2026 confirms what the digital health data has been signalling for two years: pharma’s productivity problem lives…

May 7, 2026 by Julien de Salaberry Read article

Digital health funding in Clinical Trials: Why Execution, Not Discovery, is Pharma’s Next Existential Bottleneck

TL;DR The Bottleneck Has Shifted: TechBio funding surged +75%. Clinical trial funding fell -30%. Trials still consume >50% of total R&D costs.…

March 31, 2026 by Galen Growth Read article

Next Generation Power Players: HealthTech 250 Reveals 50 Emerging Digital Health Startups in Top Clusters

TL;DR A Shortcut to the Next Generation: Amidst a maturing market that saw $29.7 billion in global digital health funding in 2025,…

March 24, 2026 by Galen Growth Read article

The Signal Beneath the Noise: What the 2026 HT250 Tells Investors About Where Digital Health Is Actually Heading

Galen Growth's proprietary ranking of the world's most promising early-stage digital health startups reveals a global sector defined by capital discipline, AI-native…

March 17, 2026 by Galen Growth Read article

Carbon Health: How a US$2.8bn Digital Health unicorn discovered clinics don’t scale like software

TL;DR Carbon Health filed for Chapter 11 protection on 2 February 2026 in the Southern District of Texas as a lender-backed “dual‑track”…

February 26, 2026 by Galen Growth Read article

The Galen Growth HealthTech 250, one year on: separating signal from noise in digital health ventures

One year after selection, the 2025 HealthTech 250 demonstrates exceptional resilience, raising $1.6B, securing 1,001 partnerships, and maintaining a 96% survival rate.…

February 12, 2026 by Galen Growth Read article

2025 Was the Year Europe Got Paid. 2026 Is the Year Europe Must Prove It Was Worth It.

TL;DR Europe Leads Growth: Europe was the fastest-growing region in 2025, with funding rising 15% year-on-year to $6.2 billion, outpacing North America.…

February 3, 2026 by Galen Growth Read article

Sword Health’s European Roots Fuel a Global Power Play

TL;DR Sword Health’s $285m acquisition of Kaia Health marks a decisive shift from fragmented point solutions to vertically integrated digital MSK platforms,…

January 29, 2026 by Galen Growth Read article

Digital Health 2026: Ten Predictions as the Industry Shifts From Hype to Hardwiring

In 2026, digital health shifts from experimentation to infrastructure. Ten predictions on clinical-grade data, operational AI, interoperability, regulation, and capital.

January 13, 2026 by Galen Growth Read article

Digital Health Funding in 2025: From Hype to Hard Results

In 2025, digital health funding reset around discipline, outcomes, and real-world impact—creating a stronger foundation for sustainable growth.

January 6, 2026 by Galen Growth Read article

In Uncertain Times, Innovation Lights the Way: Year-End Reflections

A year-end reflection on how healthcare innovation, AI, and digital health matured in 2025 despite geopolitical and economic uncertainty.

December 30, 2025 by Galen Growth Read article

The Twelve Days of Digital Health (2025 Edition)

This article provides a structured, evidence-led overview of digital health trends in 2025, covering pharma, payers, providers, regulators, and health technology vendors…

December 23, 2025 by Galen Growth Read article